Top Banner
1 a Novartis company A Step-wise Approach for Leachables & Extractables Evaluation in pMDI Product Development Andrea Mieth Technical Development, Sandoz Development Center Rudolstadt, Germany IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31 st of March 2011 Agenda 1. Regulatory requirements 2. Step-wise approach according to PQRI guideline 3. Critical assessment of the packaging system 4. Case Study I: Controlled Extraction Study 5. Case Study II: Formulation development with DoE 6. Case Study III: Correlation of L&E 7. Conclusions
12

A Step-wise Approach for Leachables & Extractables ... · PDF fileA Step-wise Approach for Leachables & Extractables Evaluation in pMDI Product Development ... ICH guideline Q6A....

Mar 27, 2018

Download

Documents

dinhkiet
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: A Step-wise Approach for Leachables & Extractables ... · PDF fileA Step-wise Approach for Leachables & Extractables Evaluation in pMDI Product Development ... ICH guideline Q6A ...

1

a Novartis company

A Step-wise Approach for Leachables & Extractables Evaluation in pMDI Product Development

Andrea MiethTechnical Development, Sandoz Development Center Rudolstadt, Germany

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

Agenda

1. Regulatory requirements

2. Step-wise approach according to PQRI guideline

3. Critical assessment of the packaging system

4. Case Study I: Controlled Extraction Study

5. Case Study II: Formulation development with DoE

6. Case Study III: Correlation of L&E

7. Conclusions

Page 2: A Step-wise Approach for Leachables & Extractables ... · PDF fileA Step-wise Approach for Leachables & Extractables Evaluation in pMDI Product Development ... ICH guideline Q6A ...

2

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

Regulatory Requirements

� Impurity guidelines

EMA guideline

Guideline on the limits of genotoxic impurities (TTC)

ICH guideline

Impurities in new drug substances (Q3A)

Impurities in new drug products (Q3B)

� EMA note for guidance

Note for guidance on specific limits for residues of metal catalysts or metal reagents

� ISO standard 10993

Biological evaluation of medical devices

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

Regulatory Requirements

� FDA guidance

Container closure systems for packaging human drugs and biologics

� EMA guideline

Guideline on plastic immediate packaging

� ICH guideline Q8

Pharmaceutical development

� ICH guideline Q6A (Specifications)

Test procedures and acceptance criteria for new drug substances and

drug products

� PQRI leachables and extractables working group (recommendationsto the FDA)

Safety thresholds and best practices for extractables & leachables in orally

inhaled and nasal drugs

Page 3: A Step-wise Approach for Leachables & Extractables ... · PDF fileA Step-wise Approach for Leachables & Extractables Evaluation in pMDI Product Development ... ICH guideline Q6A ...

3

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

Leachable and Extractable Testing

Step 1

Step 2

Step 5

Step 3

Step 4

CES (Controlled Extraction Study)

Correlation of L&E

Leachables study

Identification of L&E above AET

Critical assessment of the packaging system

� Step-wise approach according to PQRI recommendations:

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

Step 1: Critical assessment of the packaging system

� Typical sources for L&E in pMDIs:

• Packaging

– Valve materials:

» Polypropylene (PP)

» Polybutylterephthalate (PBT)

» Polyoxymethylene (POM)

» Polychloroprene (PC)

» Ethylenepropylenediene monomer (EPDM)

» Polyamide (PA)

» Metals

» Lubricants

» …

– Can

» Coating material

» Metal

Gaskets

Stem

Spring

Body

Ring

• Typical leaching compounds

» Base material oligomers

» Antioxidants

» Processing aids

» Vulcanization agents

» Phthalates

» Fillers

» Metals

» …

Page 4: A Step-wise Approach for Leachables & Extractables ... · PDF fileA Step-wise Approach for Leachables & Extractables Evaluation in pMDI Product Development ... ICH guideline Q6A ...

4

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

Step 2: Controlled Extraction Study

� Multiple solvents with differing polarities

» Methylene chloride

» Ethanol

» Hexane

� Multiple extraction techniques

» Soxhlet

» MASE® (Microwave Accelerated Solvent Extraction)

» ASE® (Accelerated Solvent Extraction)

� Multiple analytical techniques

» GC (semivolatile and volatile organic compounds (e.g. antioxidants)) • MS (identification and quantification)

• FID (quantification)

» LC (non volatile organic compounds (e.g. polymer oligomers))• MS (identification and quantification )

• HPLC-UV (quantification)

» ICP-MS or ICP-AAS» …

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

0

0.05

0.10

0.15

0.20

0.25

ethanol hexane dichloromethane

Conce

ntr

ation [

µg

/can]

ASE MASE Soxhlet

Step 2: Controlled Extraction Study

� Screening extraction

• Define extraction solvent and extraction system for each polymermaterial

Extractable 1

Page 5: A Step-wise Approach for Leachables & Extractables ... · PDF fileA Step-wise Approach for Leachables & Extractables Evaluation in pMDI Product Development ... ICH guideline Q6A ...

5

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

Step 2: Controlled Extraction Study

� Extraction optimization

• Define optimum extraction conditions with DoE for each analyte

– Relevant parameters for ASE® extraction

» Extraction time

» Extraction temperature

» Extraction cycles

» Grinding

» Pressure

Optimization with DoEfractional factorial design

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

Step 2: Controlled Extraction Study

full factorial design2³ experiments

fractional factorial design2³-1 experiments

Fractional factorial design for CES with 5 factors

Benefit: � 16 experiments (25-1) compared to 32 (25) experiments� numerical model for prediction of extractable concentration in extract

Cost: � effect can be confounded

t

T

c

t

T

c

Page 6: A Step-wise Approach for Leachables & Extractables ... · PDF fileA Step-wise Approach for Leachables & Extractables Evaluation in pMDI Product Development ... ICH guideline Q6A ...

6

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

Step 2: Controlled Extraction Study

� Extraction optimization

• Define optimum extraction conditions with DoE-approach for each analyte (R² = 0.99)

-10

0

10

20

30

40

50

Effects

for

extr

acta

ble

[%

]

Time** Pressure Temperature* Grinding** Cycles*

* : p<0.05, ** : p<0.01, *** : p<0.001

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

Step 3: Leachables study

� Leachable profile is extremely dependant on the formulation

• Propellant

• Typical excipients

» Fatty acid

» Ethanol

» PEG

» PVP

� fractional factorial experimental design (DoE)

» Cost: 16 experiments» Benefit: numerical model

for prediction of leachable

concentration in formulation

� Formulation development with regard to low leachable levels

Page 7: A Step-wise Approach for Leachables &amp; Extractables ... · PDF fileA Step-wise Approach for Leachables &amp; Extractables Evaluation in pMDI Product Development ... ICH guideline Q6A ...

7

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

Step 3: Leachables study

� Optimize formulation with regard to leachable levels

• Approach: fractional factorial experimental design (DoE; R² = 0.98)

-20

-10

0

10

20

30

40

Effects

for

leacha

ble

Propellant* Ethanol*** PEG** Fatty acid*PVP*

* : p<0.05, ** : p<0.01, *** : p<0.001

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

� Response surface

• Minimisation of leachable concentration in formulation

Step 3: Leachables study

-5.00

-2.50

0.00

2.50

5.00

-1.00

-0.50

0.00

0.50

1.00

-20

0

20

40

60

80

100

B: HFA

C: ethanol ethanol

propallent

ethanol

propallent

ethanol

Page 8: A Step-wise Approach for Leachables &amp; Extractables ... · PDF fileA Step-wise Approach for Leachables &amp; Extractables Evaluation in pMDI Product Development ... ICH guideline Q6A ...

8

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

� Minimisation of leachable concentration in formulation

Step 3: Leachables study

Inte

nsity

[AU

]

100

200

300

400

500

600

700

800

18 19 20 21 22 23 24

Time [min]

formulation 2

formulation 1

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

0

100

200

300

400

500

600

700

800

18 19 20 21 22 23 24 25 26[min]

Inte

nsit

ät

Step 4: Identification of E&L above AET

Inte

nsity

[mA

U]

AET

� Identification of leachables

[ ]

[ ]µg/gm

valve) / (1can×AET =AET

µg/cann ×n

day / µg0.15=AET

valve / material valveE

can / actuations labeledday / actuations

time [min]

Page 9: A Step-wise Approach for Leachables &amp; Extractables ... · PDF fileA Step-wise Approach for Leachables &amp; Extractables Evaluation in pMDI Product Development ... ICH guideline Q6A ...

9

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

Step 4: Identification of E&L above AET

� Identification of leachables

� GC-MS, LC-MS, NMR, UV, IR, X-ray, elemental analysis…

• Mass spectrum:

– Library search

– Compare molecular weight and fragmentation behavior

– Mass spectrum and chromatographic retention time match to

authentic reference substance

» Availability of reference substance

» Preparative HPLC and identification

» Contract synthesis labs

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

� Qualitative correlation

• extractables and leachables profiles should comply qualitatively

Step 5: Correlation of E&L

5 6 7 8 9

250

500

750

Extractables chromatogram

Leachable chromatogram

Matrix chromatogram

time [min]

Inte

nsity

[mA

U]

10

1000

Page 10: A Step-wise Approach for Leachables &amp; Extractables ... · PDF fileA Step-wise Approach for Leachables &amp; Extractables Evaluation in pMDI Product Development ... ICH guideline Q6A ...

10

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

� Qualitative correlation

• extractables and leachables profiles should comply qualitatively

Step 5: Correlation of E&L

10 11 12 13 14

250

500

750

time [min]

Inte

nsity

[mA

U]

15

1000

Extractables chromatogram

Leachable chromatogram

Matrix chromatogram

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

Step 5: Correlation of E&L

� Quantitative correlation

• levels of leachables are generally less than the levels of extractables

0

500

1000

1500

2000

2500

3000

0 3000

co

nce

ntr

atio

n [

µg

/ca

n]

Leachables

Extractables

Lot 1 Lot 2 Lot 3

Page 11: A Step-wise Approach for Leachables &amp; Extractables ... · PDF fileA Step-wise Approach for Leachables &amp; Extractables Evaluation in pMDI Product Development ... ICH guideline Q6A ...

11

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

Conclusions

� Step-wise approach for E&L is necessary for a successful product development

� Design of extraction studies has a high impact on extractable profile

� Extraction conditions need to be optimized considering the materials used in the pMDI

� CES of utmost importance for following leachable studies

� Accelerated formulation development by thorough understanding ofLeachable formulation interactions

� Establish E&L correlation to replace routine Leachable testing by control of raw material

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

Acknowledgement

� SDC Rudolstadt

� Cheryl Stults

� FSU Jena

Page 12: A Step-wise Approach for Leachables &amp; Extractables ... · PDF fileA Step-wise Approach for Leachables &amp; Extractables Evaluation in pMDI Product Development ... ICH guideline Q6A ...

12

IPAC RS 2011 | A. Mieth | Sandoz SDC Rudolstadt | 31st of March 2011

Discussion

Thank you for your attention…